Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction-Reference-Cited by-同舟云学术

Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction

Published:2018-02-27 Issue:1 Volume:5 Page:3-11
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Ibrahim Nasrien E¹²,Gaggin Hanna K¹²³,Turchin Alexander²³⁴,Patel Harshali K⁵,Song Yang³,Trebnick April³,Doros Gheorghe³⁶,Maya Juan F⁵,Cannon Christopher P²³⁷,Januzzi James L¹²³

Affiliation:

1. Division of Cardiology, Massachusetts General Hospital, Yawkey 5B, Boston, MA, USA

2. Harvard Medical School, Boston, MA, USA

3. Cardiometabolic Trial, Baim Institute for Clinical Research, Boston, MA, USA

4. Division of Endocrinology, Brigham and Women’s Hospital, Boston, MA, USA

5. Amgen Inc, Thousand Oaks, CA, USA

6. Biostatistics, Boston University School of Public Health, Boston, MA, USA

7. Division of Cardiology, Brigham and Women’s Hospital, Boston, MA, USA

Funder

Amgen, Inc.

Dennis and Marilyn Barry Fellowship in Cardiology

Clark Fund for Cardiac Research Innovation

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/article-pdf/5/1/3/27418294/pvy011.pdf

Reference22 articles.

1. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study;Swedberg;Lancet,2010

2. The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: outcome Study With Tolvaptan) trial;Greene;JACC Heart Fail,2013

3. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure;McAlister;Ann Intern Med,2009

4. Knowledge gaps in cardiovascular care of older adults: a scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society: executive summary;Rich;J Am Geriatr Soc,2016

5. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure;Yancy;J Am Coll Cardiol,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction;Heart Failure Reviews;2024-09-13

2. A Systematic Review and Meta-Analysis of Randomised Controlled Trials Assessing Clinical and Haemodynamic Outcomes of Ivabradine in Heart Failure With Reduced Ejection Fraction Patients;Heart, Lung and Circulation;2024-07

3. GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis;Clinical Research in Cardiology;2024-01-22

4. Expert Consensus on Ivabradine-based Therapy for Heart Rate Management in Chronic Coronary Syndrome and Heart Failure with Reduced Ejection Fraction in India;Current Cardiology Reviews;2023-09

5. Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism;Life;2023-04-16